Palivizumab use during respiratory syncytial virus outbreak in the neonatal intensive care unit.
S
S
Alan
E
E
Okulu
A
A
Kiliç
B
B
Atasay
S
S
Arsan
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage*; D003428:Cross Infection / Q000453:epidemiology*; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007235:Infant, Premature, Diseases; D008297:Male; D008403:Mass Screening / Q000379:methods*; D018357:Respiratory Syncytial Virus Infections / Q000453:epidemiology*; D018113:Respiratory Syncytial Virus, Human / Q000302:isolation & purification*
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents